Novartis Patient Organization Funding

AMBER Tx General

Strategy Notes

This is a general funding page for patient organizations, not a specific programme for startups or digital health infrastructure. The venture's focus on prescription drug access in Nigeria could align with Novartis's patient access goals, but the programme appears to target established patient groups rather than early-stage tech ventures.

Key Materials

—

Your Notes

Status & Deadline

Status: INELIGIBLE
Deadline: —
Cycle: rolling
Amount: —
Type: grant
URL: Apply

Update Status

Log Application

AI Pipeline

Research Programme Generate Draft

Status History

2026-07-28 OPEN → INELIGIBLE · The programme targets established patient organizations, not individual researchers or early-stage tech ventures. The applicant is an independent researcher and pharmacist, not a patient organization.